Dalfampridine in the treatment of primary fatigue in patients with multiple sclerosis: a randomized clinical trail.

Shirin MavandadiSepideh PaybastMonirsadat MirzadehHossein Mozhdehipanah

Published in: Acta neurologica Belgica (2024)

The present study revealed a positive short-term effect of extended-release fampridine on MFIS in PwMS. However, this effect was not significantly superior to the placebo.

Keyphrases

single cell
sleep quality
physical activity
clinical trial
depressive symptoms
phase iii
replacement therapy